{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T03:02:53Z","timestamp":1793674973560,"version":"4.5.1"},"reference-count":33,"publisher":"Wiley","issue":"2","license":[{"start":{"date-parts":[[2015,1,27]],"date-time":"2015-01-27T00:00:00Z","timestamp":1422316800000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Clin Experimental Allergy"],"published-print":{"date-parts":[[2015,2]]},"abstract":"<jats:title>Summary<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>\n                      Chronic rhinosinusitis (\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      ) is a heterogeneous disease with an uncertain pathogenesis. Group 2 innate lymphoid cells (\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s) represent a recently discovered cell population which has been implicated in driving Th2 inflammation in\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      ; however, their relationship with clinical disease characteristics has yet to be investigated.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Objective<\/jats:title>\n                    <jats:p>\n                      The aim of this study was to identify\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s in sinus mucosa in patients with\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      and controls and compare\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s across characteristics of disease.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>\n                      A cross\u2010sectional study of patients with\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      undergoing endoscopic sinus surgery was conducted. Sinus mucosal biopsies were obtained during surgery and control tissue from patients undergoing pituitary tumour resection through transphenoidal approach.\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s were identified as\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      45\n                      <jats:sup>+<\/jats:sup>\n                      Lin\n                      <jats:sup>\u2212<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      127\n                      <jats:sup>+<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      4\n                      <jats:sup>\u2212<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      8\n                      <jats:sup>\u2212<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CRTH<\/jats:styled-content>\n                      2(\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      294)\n                      <jats:sup>+<\/jats:sup>\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      161\n                      <jats:sup>+<\/jats:sup>\n                      cells in single cell suspensions through flow cytometry.\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 frequencies, measured as a percentage of\n                      <jats:styled-content style=\"fixed-case\">CD<\/jats:styled-content>\n                      45\n                      <jats:sup>+<\/jats:sup>\n                      cells, were compared across\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      phenotype, endotype, inflammatory\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      subtype and other disease characteristics including blood eosinophils, serum IgE, asthma status and nasal symptom score.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      35 patients (40% female, age 48\u00a0\u00b1\u00a017\u00a0years) including 13 with eosinophilic\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      (\n                      <jats:styled-content style=\"fixed-case\">eCRS<\/jats:styled-content>\n                      ), 13 with non\u2010\n                      <jats:styled-content style=\"fixed-case\">eCRS<\/jats:styled-content>\n                      and 9 controls were recruited.\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2 frequencies were associated with the presence of nasal polyps (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.002) as well as high tissue eosinophilia (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.004) and eosinophil\u2010dominant\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.001) (Mann\u2013Whitney\n                      <jats:italic>U<\/jats:italic>\n                      ). They were also associated with increased blood eosinophilia (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.005). There were no significant associations found between\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s and serum total IgE and allergic disease. In the\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      with nasal polyps (\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      w\n                      <jats:styled-content style=\"fixed-case\">NP<\/jats:styled-content>\n                      ) population,\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s were increased in patients with co\u2010existing asthma (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.03).\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s were also correlated with worsening nasal symptom score in\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      (\n                      <jats:italic>P<\/jats:italic>\n                      \u00a0=\u00a00.04).\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion and clinical relevance<\/jats:title>\n                    <jats:p>\n                      As\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s are elevated in patients with\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      w\n                      <jats:styled-content style=\"fixed-case\">NP<\/jats:styled-content>\n                      , they may drive nasal polyp formation in\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      .\n                      <jats:styled-content style=\"fixed-case\">ILC<\/jats:styled-content>\n                      2s are also linked with high tissue and blood eosinophilia and have a potential role in the activation and survival of eosinophils during the Th2 immune response. The association of innate lymphoid cells in\n                      <jats:styled-content style=\"fixed-case\">CRS<\/jats:styled-content>\n                      provides insights into its pathogenesis.\n                    <\/jats:p>\n                  <\/jats:sec>","DOI":"10.1111\/cea.12462","type":"journal-article","created":{"date-parts":[[2014,11,28]],"date-time":"2014-11-28T10:57:00Z","timestamp":1417172220000},"page":"394-403","source":"Crossref","is-referenced-by-count":144,"title":["Group 2 innate lymphoid cells (\n                    <scp>ILC<\/scp>\n                    2s) are increased in chronic rhinosinusitis with nasal polyps or eosinophilia"],"prefix":"10.1111","volume":"45","author":[{"given":"J.","family":"Ho","sequence":"first","affiliation":[{"name":"St Vincent's Clinical School Faculty of Medicine University of New South Wales Sydney NSW Australia"},{"name":"Rhinology and Skull Base Research Group St Vincent's Centre for Applied Medical Research University of New South Wales Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Bailey","sequence":"additional","affiliation":[{"name":"St Vincent's Centre for Applied Medical Research University of New South Wales Sydney NSW Australia"},{"name":"The Kirby Institute for Infection and Immunity University of New South Wales Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"J.","family":"Zaunders","sequence":"additional","affiliation":[{"name":"St Vincent's Centre for Applied Medical Research University of New South Wales Sydney NSW Australia"},{"name":"The Kirby Institute for Infection and Immunity University of New South Wales Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"N.","family":"Mrad","sequence":"additional","affiliation":[{"name":"The Kirby Institute for Infection and Immunity University of New South Wales Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R.","family":"Sacks","sequence":"additional","affiliation":[{"name":"The Kirby Institute for Infection and Immunity University of New South Wales Sydney NSW Australia"},{"name":"Australian School of Advanced Medicine Macquarie University Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"W.","family":"Sewell","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School Faculty of Medicine University of New South Wales Sydney NSW Australia"},{"name":"Immunology Department Garvan Institute of Medical Research Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"R. J.","family":"Harvey","sequence":"additional","affiliation":[{"name":"St Vincent's Clinical School Faculty of Medicine University of New South Wales Sydney NSW Australia"},{"name":"Rhinology and Skull Base Research Group St Vincent's Centre for Applied Medical Research University of New South Wales Sydney NSW Australia"},{"name":"Australian School of Advanced Medicine Macquarie University Sydney NSW Australia"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2015,1,27]]},"reference":[{"key":"e_1_2_8_2_1","doi-asserted-by":"crossref","first-page":"1","DOI":"10.4193\/Rhino12.000","article-title":"EPOS 2012: European position paper on rhinosinusitis and nasal polyps 2012. A summary for otorhinolaryngologists","volume":"50","author":"Fokkens WJ","year":"2012","journal-title":"Rhinology"},{"key":"e_1_2_8_3_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.08.004"},{"key":"e_1_2_8_4_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0b013e32835bc3f9"},{"key":"e_1_2_8_5_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21032"},{"key":"e_1_2_8_6_1","doi-asserted-by":"publisher","DOI":"10.1111\/cea.12296"},{"key":"e_1_2_8_7_1","doi-asserted-by":"publisher","DOI":"10.1016\/S1074-7613(01)00243-6"},{"key":"e_1_2_8_8_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08900"},{"key":"e_1_2_8_9_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature08636"},{"key":"e_1_2_8_10_1","doi-asserted-by":"publisher","DOI":"10.1073\/pnas.1201042109"},{"key":"e_1_2_8_11_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.09.041"},{"key":"e_1_2_8_12_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2011.12.020"},{"key":"e_1_2_8_13_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2011.10.036"},{"key":"e_1_2_8_14_1","doi-asserted-by":"publisher","DOI":"10.1002\/eji.201142018"},{"key":"e_1_2_8_15_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2131"},{"key":"e_1_2_8_16_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2104"},{"key":"e_1_2_8_17_1","doi-asserted-by":"publisher","DOI":"10.1164\/rccm.201212-2227OC"},{"key":"e_1_2_8_18_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2012.08.015"},{"key":"e_1_2_8_19_1","doi-asserted-by":"publisher","DOI":"10.1097\/MOO.0b013e3283350053"},{"key":"e_1_2_8_20_1","doi-asserted-by":"publisher","DOI":"10.1002\/alr.21082"},{"key":"e_1_2_8_21_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.immuni.2009.08.014"},{"key":"e_1_2_8_22_1","doi-asserted-by":"publisher","DOI":"10.1146\/annurev-immunol-020711-075053"},{"key":"e_1_2_8_23_1","doi-asserted-by":"publisher","DOI":"10.1007\/s11882-009-0031-4"},{"key":"e_1_2_8_24_1","doi-asserted-by":"publisher","DOI":"10.1111\/j.1398-9995.2006.01225.x"},{"key":"e_1_2_8_25_1","doi-asserted-by":"publisher","DOI":"10.1189\/jlb.0311160"},{"key":"e_1_2_8_26_1","doi-asserted-by":"publisher","DOI":"10.1038\/nature12526"},{"key":"e_1_2_8_27_1","doi-asserted-by":"publisher","DOI":"10.4049\/jimmunol.1101270"},{"key":"e_1_2_8_28_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2010.11.050"},{"key":"e_1_2_8_29_1","doi-asserted-by":"publisher","DOI":"10.1067\/mai.2001.118600"},{"key":"e_1_2_8_30_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.coi.2012.08.009"},{"key":"e_1_2_8_31_1","doi-asserted-by":"publisher","DOI":"10.5694\/j.1326-5377.2006.tb00693.x"},{"key":"e_1_2_8_32_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2004.07.013"},{"key":"e_1_2_8_33_1","doi-asserted-by":"publisher","DOI":"10.1016\/j.jaci.2012.05.018"},{"key":"e_1_2_8_34_1","doi-asserted-by":"publisher","DOI":"10.1038\/ni.2142"}],"container-title":["Clinical &amp; Experimental Allergy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1111%2Fcea.12462","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1111\/cea.12462","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,2]],"date-time":"2023-10-02T23:28:48Z","timestamp":1696289328000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1111\/cea.12462"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,1,27]]},"references-count":33,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2015,2]]}},"alternative-id":["10.1111\/cea.12462"],"URL":"https:\/\/doi.org\/10.1111\/cea.12462","archive":["Portico"],"relation":{},"ISSN":["0954-7894","1365-2222"],"issn-type":[{"value":"0954-7894","type":"print"},{"value":"1365-2222","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,1,27]]}}}